CAMERHOIGN 15 %
TROLAMINE SALICYLATE : 15 % · DIN 02241661 · SEAFORD PHARMACEUTICALS INC
Health Canada status: APPROVED
What is CAMERHOIGN?
CAMERHOIGN 15 % contains TROLAMINE SALICYLATE : 15 %. It is listed in the Health Canada Drug Product Database under DIN 02241661, held by SEAFORD PHARMACEUTICALS INC, supplied as GEL for TOPICAL administration. Health Canada currently lists it as approved, status dated 27-Jan-2000. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02241661 |
|---|---|
| Brand name | CAMERHOIGN |
| Generic / active ingredient | TROLAMINE SALICYLATE : 15 % |
| Manufacturer | SEAFORD PHARMACEUTICALS INC |
| Strength | 15 % |
| Dosage form | GEL |
| Route of administration | TOPICAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | M02AC PREPARATIONS WITH SALICYLIC ACID DERIVATIVES |
| AHFS class | 28:08.04.24 |
| Biosimilar | No |
| Health Canada status | APPROVED |
| Status date | 27-Jan-2000 |
What can be used instead?
Other Canadian products sharing ATC code M02AC PREPARATIONS WITH SALICYLIC ACID DERIVATIVES. 11 of 120 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ARTHRITIS PAIN RELIEF | 10 % | LOTION | CHURCH & DWIGHT CANADA CORP | MARKETED | DIN 02486725 |
| EXTRA STRENGTH ASPERCREME CREME RUB 15% | 15 % | CREAM | SANOFI CONSUMER HEALTH INC | MARKETED | DIN 02074702 |
| FLEXACRÈME PAIN RELIEF RUB | 15 % | CREAM | CRLS | MARKETED | DIN 02516713 |
| MUSCLE & JOINT NO ODOUR EXTRA STRENGTH | 20 % | CREAM | CHURCH & DWIGHT CANADA CORP | MARKETED | DIN 02473135 |
| MUSCLE & JOINT NO ODOUR REGULAR STRENGTH | 13.3 % | CREAM | CHURCH & DWIGHT CANADA CORP | MARKETED | DIN 02473143 |
| MYOFLEX EXTRA STRENGTH | 15 % | CREAM | EXZELL PHARMA INC | MARKETED | DIN 02226022 |
| MYOFLEX MAXIMUM STRENGTH | 20 % | CREAM | EXZELL PHARMA INC | MARKETED | DIN 02244573 |
| MYOFLEX REGULAR STRENGTH | 10 % | CREAM | EXZELL PHARMA INC | MARKETED | DIN 02152827 |
| PAIN RELIEF CREAM EXTRA STRENGTH | 20 % | CREAM | CRLS | MARKETED | DIN 02413442 |
| PAIN RELIEF CREAM REGULAR STRENGTH | 13.3 % | CREAM | CRLS | MARKETED | DIN 02358131 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.